Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain
Por:
Puig, L, de Morales, JGR, Dauden, E, Andreu, JL, Cervera, R, Adan, A, Tarsal, S, Escobar, C, Hinojosa, J, Palau, J, Arraiza, A, Casado, P, Codesido, M, Pascual, C, Saldana, R, Gil, A
Publicada:
20 mar 2019
Resumen:
Background: Immune-mediated inflammatory diseases (IMID) are chronic and highly disabling diseases that share inflammatory sequences and immtutological dysregulations. Considered as a disease in itself; the prevalence of IMID is virtually unknown. The aim of this study was to assess the prevalence of 10 selected UDI, including rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondvlitis, ulcerative colitis, Crohn's disease, systemic lupus erythematosus, hictiadenitis suppurative, sarcoidosis and uveitis in Spain.
Methods: A cross-sectional epidemiological study of point prevalence was made. Thu study was carried out through a series of computerized interviews in households chosen at random in 17 autonomous commurities in Spain. A structured questionnaire was used to determine the frequency of diagnosis and the concurrence of 10 IMID in the respondents and other individuals belonging to the same family nucleus. The point prevalence estimates were used and compared with the objective of determining the frequency of IMID by age, sex and communities. The data were processed using Excel 2016 (Microsoft, Redmond, WA, USA) and the SPSS V.019 system (IBM Corp. Armonk, NY, USA) for statistical analysis using the usual statistical tests in this type of studies.
Results: Of the 7,980 respondents, 510 were diagnosed with an IMID, representing a cross-sectional study of 6.39% (95% CI: 6.02-6.76). One, two, three or more members of the family were affected in 87.2%, 7.8% and 5% of positive relatives in IMID, respectively. The most recurrent diseases were psoriasis (2.69% [95% CI: 2.32-3.06]) and rheumatic arthritis (1.07% [95% CI: 0.70-1.44]). There were differences in prevalence due to sex (p = 0.004) and age (p = 0.000). No significant difference: were identified related to geo-graphic location (p = 0.819). Attendance of at least 2 IMID was reported in 8.9% of respondents.
Conclusions: The overall prevalence was of the IMID studied was 634%, psoriasis being the most frequent with 2.69%. This study constitutes an initial step to consider IMID as an independent disease within the health system..
Filiaciones:
Puig, L:
Hosp Santa Creu & Sant Pau, Serv Dermatol, Barcelona, Spain
de Morales, JGR:
Complejo Hosp Univ Leon, Serv Inmunol, Leon, Spain
Dauden, E:
Hosp Univ La Princess, Serv Dermatol, Madrid, Spain
Andreu, JL:
Hosp Univ Puerta Hierro Majadahonda, Serv Reumatol, Madrid, Spain
Cervera, R:
Hosp Clin Barcelona, Serv Enfermedades Autoinmunes, Barcelona, Spain
Adan, A:
Hosp Clin Barcelona, Inst Oftalmol, Barcelona, Spain
Tarsal, S:
Hosp Univ Vall dHebron, Inst Recerca, Grp Invest Reumatol, Barcelona, Spain
Escobar, C:
UNIMID, Asociac Personas Con Enfermedades Cron Inflamator, Madrid, Spain
Hinojosa, J:
Hosp Manises, Serv Med Digest, Valencia, Spain
Palau, J:
Dept Salud La Ribera, Valencia, Spain
Arraiza, A:
Osakidetza, Vitoria, Spain
Casado, P:
Minist Senidad, Serv Sociales & Igueldad, Calided & Cohes, Madrid, Spain
Codesido, M:
Hosp Lisa Pardo de Aravaca, Madrid, Spain
Pascual, C:
Serv Madrileno Salud, Direct Gen Coordinat Asistencia Sanitaria, Madrid, Spain
Saldana, R:
Confederac ACC Confederat Efectedos Crohn & Colit, Madrid, Spain
Gil, A:
Univ Rey Juan Carlos, Med Prevent & Salud Publ, Madrid, Spain
|